Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7] annulene-2-carboxylic acid and its use for the treatment of cancer

US Patent 11260057 · Granted Mar 1, 2022

Estimated economic value: $10,097,000

Assignee

Inventors

View full patent text on Google Patents →